Skip to main content
OpenTrials

Clinical trial condition

Gastric Adenocarcinoma

Explore clinical trials studying Gastric Adenocarcinoma. Study availability and eligibility vary by location and protocol.

200 public trials 62 recruiting studies
Refine in advanced search Browse all conditions

Gastric Adenocarcinoma trial results

Recruiting

Timing of Comprehensive Local Treatment After First-Line Systemic Therapy in Oligometastatic Esophageal or Gastric Adenocarcinoma

NCT07000253

Conditions
Digestive System Diseases, Digestive System Neoplasms, Esophageal Cancer, +14 more
Locations
  • Amsterdam University Medical Center Amsterdam, Netherlands
  • UMC Utrecht Utrecht, Netherlands
  • University of Oslo Oslo, Norway
  • University of North Norway Tromsø, Norway
View Trial Details
Recruiting

A Study of KK2269 in Adult Participants With Solid Tumors

NCT06266299

Conditions
Adenocarcinoma Of Esophagus, Advanced Solid Tumor, Bronchial Neoplasms, +18 more
Locations
  • Mayo Clinic Arizona Scottsdale, Arizona, United States
  • City Of Hope National Medical Center Duarte, California, United States
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
  • Mayo Clinic Jacksonville Jacksonville, Florida, United States
View all 32 locations
View Trial Details
Recruiting

A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers

NCT07544589

Conditions
Adenocarcinoma Of Esophagus, Adenoviridae Infections, Colonic Diseases, +17 more
Locations
  • City of Hope Duarte, California, United States
  • University of Cincinnati Cancer Center Cincinnati, Ohio, United States
  • Tennessee Oncology Nashville, Tennessee, United States
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
View Trial Details
Recruiting

DEWI: Watch-and-Wait With Dostarlimab in Localized dMMR/MSI-H Gastric/GEJ Adenocarcinoma Phase II Study

NCT06059495

Conditions
Adenocarcinoma - GEJ, Gastric Adenocarcinoma
Locations
  • CHRU Lille Lille, France
  • Besancon University Hospital Center Besançon, France
  • Centre Hospitalier Universitaire De Bordeaux Bordeaux, France
  • Centre Hospitalier Regional Et Universitaire De Brest Brest, France
View all 18 locations
View Trial Details
Recruiting

Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity

NCT07001748

Conditions
Abdominal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +7 more
Locations
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
  • Stanford Cancer Institute Palo Alto Palo Alto, California, United States
View all 78 locations
View Trial Details
Recruiting

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

NCT07182149

Conditions
Adenocarcinoma Of Esophagus, Adnexal Diseases, Breast Diseases, +39 more
Locations
  • Normunity Investigational Site Denver, Colorado, United States
  • Normunity Investigational Site New Haven, Connecticut, United States
  • Normunity Investigational Site Minneapolis, Minnesota, United States
  • Normunity Investigational Site Maumee, Ohio, United States
View all 18 locations
View Trial Details
Recruiting

Perioperative HLX10 (Serplulimab) With S-1+Oxaliplatin (SOX) in Locally Advanced and PD-L1-Positive Gastric or Esophagogastric Junction Adenocarcinoma

NCT07699939

Conditions
Adenocarcinoma, Carcinoma, Gastric Adenocarcinoma, +4 more
Locations
  • Chiba Cancer Center Chiba, Japan
  • Kyushu Cancer Center Fukuoka, Japan
  • Gifu University Hospital Gifu, Japan
  • Gunma University Hospital Maebashi, Gunma, Japan
View all 18 locations
View Trial Details

Related conditions